Related Experiment Videos
Grapefruit juice has no effect on quinine pharmacokinetics
P C Ho1, S C Chalcroft, P F Coville
1School of Pharmacy, University of Otago, Dunedin, New Zealand.
European Journal of Clinical Pharmacology
|August 24, 1999
Summary
Grapefruit juice does not significantly affect how the body processes the malaria drug quinine. Patients can safely consume grapefruit juice while taking quinine without altering its pharmacokinetics.
Area of Science:
- Pharmacology
- Drug Metabolism
- Clinical Pharmacokinetics
Background:
- Quinine is primarily metabolized by human liver CYP3A4.
- Grapefruit juice is known to inhibit CYP3A4 activity.
- Potential for drug-drug interactions exists between quinine and grapefruit juice.
Purpose of the Study:
- To investigate the effect of grapefruit juice on the pharmacokinetics of quinine.
- To determine if grapefruit juice alters quinine metabolism or elimination following oral administration.
Main Methods:
- A randomized cross-over study involving ten healthy volunteers.
- Administration of quinine sulfate (600 mg) with orange juice (control), full-strength, or half-strength grapefruit juice.
- Collection and analysis of plasma and urine samples over 48 hours to measure quinine and its metabolite, 3-hydroxyquinine, using high-performance liquid chromatography.
Main Results:
- Grapefruit juice did not significantly alter the oral pharmacokinetics of quinine.
- No significant differences were observed in Cmax, tmax, t1/2, AUC, or oral clearance of quinine.
- A slight alteration in the pharmacokinetics of the 3-hydroxyquinine metabolite was noted, with lower Cmax observed with full-strength grapefruit juice.
Conclusions:
- No significant pharmacokinetic interaction between quinine and grapefruit juice.
- Patients do not need to avoid grapefruit juice when taking quinine.
- The lack of interaction suggests CYP3A4 inhibition by grapefruit juice primarily occurs in the gut, not the liver, for quinine metabolism.